Literature DB >> 29396315

Historical perspective and nomenclature of potentially malignant or potentially premalignant oral epithelial lesions with emphasis on leukoplakia-some suggestions for modifications.

Isaäc van der Waal1.   

Abstract

Of the potentially (pre)maligant oral epithelial lesions, leukoplakia is the most common. A brief overview of the various definitions of leukoplakia that have been used in the past is presented here. A proposal has been made to modify the current definition. Clinically, for decades, leukoplakias have been divided into homogeneous and nonhomogeneous leukoplakias and further into different subtypes. A proposal has been made to slightly rearrange these subtypes. Furthermore, attention has been paid to a number of keratotic lesions that have been reported in the literature. It is expected that the increasing knowledge on carcinogenesis, including various genetic aspects, will be reflected in the definition of oral potentially (pre)malignant lesions in the near future.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29396315     DOI: 10.1016/j.oooo.2017.11.023

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  10 in total

1.  Causal inference and directed acyclic graph: An epidemiological concept much needed for oral submucous fibrosis.

Authors:  Naman R Rao; Chandramani B More; Rahi M Brahmbhatt; Youbai Chen; Wai-Kit Ming
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-03

2.  Photodynamic therapy guidelines for the management of oral leucoplakia.

Authors:  Qianming Chen; Hongxia Dan; Fan Tang; Jiongke Wang; Xiaoying Li; Junxin Cheng; Hang Zhao; Xin Zeng
Journal:  Int J Oral Sci       Date:  2019-04-11       Impact factor: 6.344

3.  Characteristics and trends of oral leukoplakia research: A bibliometric study of the 100 most cited articles.

Authors:  Wei Liu; Yu Zhang; Lan Wu; Xi Yang; Linjun Shi
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 4.  Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management.

Authors:  Naman R Rao; Alessandro Villa; Chandramani B More; Ruwan D Jayasinghe; Alexander Ross Kerr; Newell W Johnson
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-01-08

5.  Analysis of octamer-binding transcription factor-4 expression in oral leukoplakia.

Authors:  Anand Siddappa Tegginamani; Vanishree Halasagundhi Shivakumar; Thomas George Kallarakkal; Siti Mazlipah Ismail; Mannil Thomas Abraham; Ahmad Termizi Bin Zamzuri
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

6.  Well-armed is well started: A population-based study to assess risk stratification in potentially premalignant oral epithelial lesions.

Authors:  Reshma Venugopal; Radhika Manoj Bavle; Sudhakara Muniswamappa; Soumya Makarla; Sreelatha S Hosthor; Punith Shetty
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

7.  Bibliometric analysis of the top-100 cited articles on oral potentially malignant disorders to guide research topic and direction.

Authors:  Liwei Ma; Xing Gao; Wei Liu
Journal:  J Dent Sci       Date:  2019-12-28       Impact factor: 2.080

8.  Multifunctional photodynamic/photothermal nano-agents for the treatment of oral leukoplakia.

Authors:  Lin Lin; Chuanhui Song; Zheng Wei; Huihui Zou; Shengwei Han; Zichen Cao; Xinyu Zhang; Guorong Zhang; Jianchuan Ran; Yu Cai; Wei Han
Journal:  J Nanobiotechnology       Date:  2022-03-04       Impact factor: 10.435

Review 9.  Difficulties in the Prognostic Study of Oral Leukoplakia: Standardisation Proposal of Follow-Up Parameters.

Authors:  Cristina Saldivia-Siracusa; Wilfredo Alejandro González-Arriagada
Journal:  Front Oral Health       Date:  2021-02-05

10.  High Prevalence of Human Papillomavirus Type 18 in Oral Potentially Malignant Disorders in Thailand.

Authors:  Nithi Kaewmaneenuan; Suree Lekawanvijit; Surawut Pongsiriwet; Vuttinun Chatupos; Anak Iamaroon
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.